Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Flavonoids | 7 | 2023 | 447 | 2.630 |
Why?
|
Veterans | 7 | 2024 | 2669 | 1.410 |
Why?
|
Diet | 20 | 2024 | 8089 | 1.230 |
Why?
|
Yogurt | 5 | 2021 | 71 | 0.900 |
Why?
|
Diet Surveys | 4 | 2021 | 1160 | 0.800 |
Why?
|
Trans Fatty Acids | 1 | 2023 | 155 | 0.790 |
Why?
|
Probiotics | 2 | 2014 | 387 | 0.680 |
Why?
|
Food Analysis | 2 | 2017 | 103 | 0.680 |
Why?
|
Nuts | 1 | 2021 | 264 | 0.650 |
Why?
|
Flavonols | 2 | 2020 | 85 | 0.590 |
Why?
|
Feeding Behavior | 8 | 2020 | 3205 | 0.550 |
Why?
|
Mortality | 3 | 2017 | 2911 | 0.530 |
Why?
|
Cardiovascular Diseases | 8 | 2023 | 15662 | 0.530 |
Why?
|
Leptin | 2 | 2023 | 1599 | 0.500 |
Why?
|
Feces | 6 | 2024 | 1511 | 0.490 |
Why?
|
Antithyroid Agents | 1 | 2014 | 72 | 0.460 |
Why?
|
Proanthocyanidins | 1 | 2013 | 20 | 0.440 |
Why?
|
Camellia sinensis | 1 | 2013 | 8 | 0.440 |
Why?
|
Overweight | 3 | 2018 | 2448 | 0.430 |
Why?
|
Atherosclerosis | 2 | 2023 | 3433 | 0.420 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2023 | 12252 | 0.400 |
Why?
|
Western Australia | 4 | 2017 | 41 | 0.390 |
Why?
|
Tunica Media | 1 | 2011 | 111 | 0.370 |
Why?
|
Nutrition Assessment | 4 | 2020 | 740 | 0.360 |
Why?
|
Carotid Artery, Common | 1 | 2011 | 174 | 0.350 |
Why?
|
Hypolipidemic Agents | 1 | 2014 | 609 | 0.340 |
Why?
|
Fruit | 4 | 2023 | 1165 | 0.330 |
Why?
|
Plant Extracts | 1 | 2013 | 499 | 0.330 |
Why?
|
Hyperlipidemias | 1 | 2014 | 772 | 0.330 |
Why?
|
Tunica Intima | 1 | 2011 | 459 | 0.320 |
Why?
|
Dietary Supplements | 2 | 2019 | 3445 | 0.310 |
Why?
|
Vegetables | 3 | 2021 | 1199 | 0.300 |
Why?
|
Health Surveys | 2 | 2020 | 4057 | 0.300 |
Why?
|
Aged | 32 | 2024 | 171502 | 0.290 |
Why?
|
Dairy Products | 1 | 2011 | 490 | 0.290 |
Why?
|
Life Style | 6 | 2022 | 3932 | 0.280 |
Why?
|
Environmental Exposure | 1 | 2021 | 4543 | 0.260 |
Why?
|
Lactobacillus acidophilus | 2 | 2014 | 21 | 0.230 |
Why?
|
Diet Records | 3 | 2021 | 426 | 0.230 |
Why?
|
Milk | 2 | 2021 | 438 | 0.230 |
Why?
|
Prospective Studies | 16 | 2023 | 54924 | 0.220 |
Why?
|
Lipids | 3 | 2021 | 3345 | 0.220 |
Why?
|
Receptors, Transferrin | 1 | 2024 | 300 | 0.210 |
Why?
|
Methylamines | 2 | 2021 | 136 | 0.210 |
Why?
|
Doxycycline | 1 | 2024 | 349 | 0.200 |
Why?
|
Aged, 80 and over | 13 | 2024 | 59626 | 0.190 |
Why?
|
Celiac Disease | 2 | 2021 | 820 | 0.190 |
Why?
|
Lignans | 1 | 2022 | 84 | 0.190 |
Why?
|
Glucose Tolerance Test | 1 | 2024 | 1183 | 0.190 |
Why?
|
Iron | 2 | 2024 | 1813 | 0.190 |
Why?
|
Middle Aged | 24 | 2024 | 223487 | 0.180 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2496 | 0.180 |
Why?
|
Female | 35 | 2024 | 397187 | 0.180 |
Why?
|
Risk Factors | 15 | 2024 | 74944 | 0.180 |
Why?
|
Risk Assessment | 2 | 2024 | 24318 | 0.180 |
Why?
|
Humans | 52 | 2024 | 768171 | 0.180 |
Why?
|
Haemophilus Infections | 1 | 2020 | 94 | 0.180 |
Why?
|
Flavones | 1 | 2020 | 66 | 0.180 |
Why?
|
Follow-Up Studies | 14 | 2023 | 39354 | 0.180 |
Why?
|
Male | 36 | 2024 | 364731 | 0.180 |
Why?
|
Anthocyanins | 1 | 2020 | 80 | 0.170 |
Why?
|
Tea | 2 | 2023 | 289 | 0.170 |
Why?
|
Glutens | 2 | 2021 | 240 | 0.170 |
Why?
|
Chemical Fractionation | 1 | 2020 | 61 | 0.170 |
Why?
|
Adiponectin | 2 | 2023 | 1117 | 0.170 |
Why?
|
Bacterial Load | 1 | 2020 | 154 | 0.160 |
Why?
|
Food | 2 | 2024 | 768 | 0.160 |
Why?
|
Stroke | 1 | 2021 | 9755 | 0.160 |
Why?
|
Factor Analysis, Statistical | 1 | 2021 | 1001 | 0.150 |
Why?
|
Anti-Bacterial Agents | 4 | 2024 | 7477 | 0.150 |
Why?
|
United States | 9 | 2024 | 73039 | 0.150 |
Why?
|
Statistics, Nonparametric | 2 | 2021 | 2862 | 0.150 |
Why?
|
Metagenome | 2 | 2021 | 465 | 0.150 |
Why?
|
Kidney | 1 | 2013 | 7064 | 0.150 |
Why?
|
Colitis, Ulcerative | 2 | 2021 | 1926 | 0.150 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2020 | 760 | 0.140 |
Why?
|
Beverages | 1 | 2023 | 819 | 0.140 |
Why?
|
Weight Loss | 2 | 2020 | 2721 | 0.140 |
Why?
|
Dietary Fiber | 1 | 2021 | 767 | 0.140 |
Why?
|
Blood Glucose | 3 | 2024 | 6431 | 0.140 |
Why?
|
Ear, Middle | 1 | 2019 | 341 | 0.140 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2018 | 174 | 0.140 |
Why?
|
Metagenomics | 4 | 2024 | 474 | 0.140 |
Why?
|
Wine | 1 | 2017 | 172 | 0.140 |
Why?
|
United States Department of Agriculture | 1 | 2016 | 47 | 0.130 |
Why?
|
Specimen Handling | 1 | 2021 | 707 | 0.130 |
Why?
|
Multivariate Analysis | 3 | 2021 | 12077 | 0.130 |
Why?
|
Nitrates | 1 | 2017 | 260 | 0.130 |
Why?
|
Malus | 1 | 2016 | 51 | 0.130 |
Why?
|
Caloric Restriction | 1 | 2018 | 301 | 0.120 |
Why?
|
Nutritional Status | 1 | 2024 | 1628 | 0.120 |
Why?
|
Dietary Fats | 1 | 2023 | 2003 | 0.120 |
Why?
|
Fatty Acids | 1 | 2023 | 1812 | 0.120 |
Why?
|
Milk, Human | 1 | 2020 | 490 | 0.120 |
Why?
|
Adult | 19 | 2023 | 223646 | 0.120 |
Why?
|
DNA, Bacterial | 1 | 2020 | 1478 | 0.120 |
Why?
|
Incidence | 7 | 2021 | 21538 | 0.120 |
Why?
|
Databases as Topic | 1 | 2016 | 472 | 0.120 |
Why?
|
Bacteria | 3 | 2020 | 2216 | 0.110 |
Why?
|
Hypertension | 1 | 2014 | 8616 | 0.110 |
Why?
|
Bifidobacterium | 1 | 2014 | 99 | 0.110 |
Why?
|
Bacillus | 1 | 2014 | 77 | 0.110 |
Why?
|
Homeostasis | 1 | 2024 | 3348 | 0.110 |
Why?
|
Colorectal Neoplasms | 2 | 2024 | 6975 | 0.100 |
Why?
|
Australia | 3 | 2023 | 1265 | 0.100 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1904 | 0.100 |
Why?
|
Insulin Resistance | 2 | 2018 | 3986 | 0.100 |
Why?
|
Intraocular Pressure | 1 | 2018 | 1304 | 0.100 |
Why?
|
Asthma | 2 | 2021 | 6291 | 0.100 |
Why?
|
Superoxides | 1 | 1993 | 389 | 0.100 |
Why?
|
Regression Analysis | 1 | 2021 | 6340 | 0.090 |
Why?
|
Cheese | 1 | 2011 | 39 | 0.090 |
Why?
|
Glaucoma, Open-Angle | 1 | 2018 | 742 | 0.090 |
Why?
|
Metabolomics | 1 | 2020 | 1674 | 0.090 |
Why?
|
Phytotherapy | 1 | 2013 | 298 | 0.090 |
Why?
|
Carotid Artery Diseases | 1 | 2017 | 879 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2021 | 1807 | 0.090 |
Why?
|
Cystic Fibrosis | 1 | 2020 | 1294 | 0.090 |
Why?
|
Cerebrovascular Disorders | 1 | 2017 | 1485 | 0.090 |
Why?
|
Double-Blind Method | 2 | 2014 | 12466 | 0.080 |
Why?
|
Gastric Mucosa | 1 | 1993 | 602 | 0.080 |
Why?
|
Hydrogen Peroxide | 1 | 1993 | 741 | 0.080 |
Why?
|
Neoplasms | 2 | 2016 | 22371 | 0.080 |
Why?
|
Proton Pump Inhibitors | 1 | 2014 | 552 | 0.080 |
Why?
|
Dementia | 1 | 2023 | 2740 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2022 | 20225 | 0.080 |
Why?
|
Hemoglobins | 1 | 2014 | 1531 | 0.070 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12543 | 0.070 |
Why?
|
Insulin | 3 | 2018 | 6610 | 0.070 |
Why?
|
Eating | 1 | 2013 | 1542 | 0.070 |
Why?
|
Accidental Falls | 1 | 2014 | 1080 | 0.070 |
Why?
|
Drug Resistance, Bacterial | 2 | 2024 | 1063 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2442 | 0.070 |
Why?
|
Body Mass Index | 2 | 2014 | 13053 | 0.070 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22380 | 0.060 |
Why?
|
Postmenopause | 1 | 2014 | 2518 | 0.060 |
Why?
|
Exercise | 1 | 2022 | 5954 | 0.060 |
Why?
|
Blood Pressure | 1 | 2021 | 8543 | 0.060 |
Why?
|
Gene Expression | 1 | 2018 | 7601 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9540 | 0.060 |
Why?
|
South Australia | 1 | 2024 | 27 | 0.060 |
Why?
|
Energy Intake | 2 | 2024 | 2146 | 0.060 |
Why?
|
Thiazines | 1 | 2024 | 38 | 0.060 |
Why?
|
Ampicillin | 1 | 2024 | 137 | 0.060 |
Why?
|
Cholesterol, HDL | 1 | 2011 | 1820 | 0.060 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2227 | 0.060 |
Why?
|
Inflammation | 2 | 2021 | 10873 | 0.060 |
Why?
|
Sucrose | 1 | 2024 | 157 | 0.060 |
Why?
|
Patient Compliance | 1 | 2014 | 2697 | 0.050 |
Why?
|
Kynurenine | 1 | 2023 | 142 | 0.050 |
Why?
|
Cohort Studies | 4 | 2024 | 41753 | 0.050 |
Why?
|
Jejunum | 1 | 2024 | 475 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2014 | 2062 | 0.050 |
Why?
|
Young Adult | 4 | 2021 | 60066 | 0.050 |
Why?
|
4-Butyrolactone | 1 | 2022 | 60 | 0.050 |
Why?
|
Health Personnel | 3 | 2021 | 3384 | 0.050 |
Why?
|
Tryptophan | 1 | 2023 | 482 | 0.050 |
Why?
|
Shellfish | 1 | 2020 | 37 | 0.050 |
Why?
|
Nova Scotia | 1 | 2020 | 33 | 0.050 |
Why?
|
Prevotella | 1 | 2021 | 81 | 0.050 |
Why?
|
Risk | 1 | 2013 | 9613 | 0.050 |
Why?
|
Odds Ratio | 1 | 2013 | 9669 | 0.040 |
Why?
|
Carrier State | 1 | 2024 | 529 | 0.040 |
Why?
|
Clarithromycin | 1 | 2020 | 87 | 0.040 |
Why?
|
Animals | 5 | 2024 | 169285 | 0.040 |
Why?
|
Haemophilus influenzae | 1 | 2020 | 177 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2016 | 10397 | 0.040 |
Why?
|
Diet, Vegetarian | 1 | 2021 | 181 | 0.040 |
Why?
|
Plaque, Atherosclerotic | 1 | 2011 | 1551 | 0.040 |
Why?
|
Sulfur | 1 | 2020 | 158 | 0.040 |
Why?
|
Azithromycin | 1 | 2020 | 201 | 0.040 |
Why?
|
Choline | 1 | 2021 | 522 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 1040 | 0.040 |
Why?
|
Ear, External | 1 | 2019 | 165 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2022 | 677 | 0.040 |
Why?
|
Micronutrients | 1 | 2021 | 390 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2024 | 16044 | 0.040 |
Why?
|
Fishes | 1 | 2020 | 606 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2018 | 352 | 0.030 |
Why?
|
Prognosis | 2 | 2018 | 30009 | 0.030 |
Why?
|
C-Peptide | 1 | 2018 | 443 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26379 | 0.030 |
Why?
|
Nasopharynx | 1 | 2019 | 420 | 0.030 |
Why?
|
Musa | 1 | 2016 | 8 | 0.030 |
Why?
|
Age Factors | 2 | 2023 | 18415 | 0.030 |
Why?
|
Diet, Fat-Restricted | 1 | 2018 | 328 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1049 | 0.030 |
Why?
|
Mental Recall | 1 | 2021 | 1226 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1793 | 0.030 |
Why?
|
Waist Circumference | 1 | 2018 | 935 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2024 | 12795 | 0.030 |
Why?
|
Diet, Mediterranean | 1 | 2021 | 748 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2020 | 1967 | 0.030 |
Why?
|
Glucose Oxidase | 1 | 1993 | 18 | 0.030 |
Why?
|
Phenanthrolines | 1 | 1993 | 49 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2278 | 0.030 |
Why?
|
Catalase | 1 | 1993 | 215 | 0.030 |
Why?
|
Glucose | 1 | 2024 | 4352 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2022 | 2744 | 0.030 |
Why?
|
Deferoxamine | 1 | 1993 | 155 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1892 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2873 | 0.020 |
Why?
|
Fasting | 1 | 2018 | 1610 | 0.020 |
Why?
|
Allopurinol | 1 | 1993 | 202 | 0.020 |
Why?
|
Nurses | 1 | 2021 | 2501 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 1993 | 596 | 0.020 |
Why?
|
Phylogeny | 1 | 2018 | 2843 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3858 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1752 | 0.020 |
Why?
|
Women's Health | 1 | 2019 | 2082 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4786 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42669 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10632 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8890 | 0.020 |
Why?
|
Stem Cells | 1 | 2019 | 3538 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9384 | 0.020 |
Why?
|
Medication Adherence | 1 | 2018 | 2187 | 0.020 |
Why?
|
Hospitalization | 2 | 2017 | 10840 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3670 | 0.020 |
Why?
|
Genotype | 1 | 2018 | 13045 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13668 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7852 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1993 | 8142 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15869 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14783 | 0.010 |
Why?
|
Mice | 1 | 2024 | 82049 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1993 | 19025 | 0.010 |
Why?
|
Rats | 1 | 1993 | 23782 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20762 | 0.010 |
Why?
|
Obesity | 1 | 2018 | 13091 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30237 | 0.010 |
Why?
|
Child | 1 | 2021 | 80917 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40220 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 89169 | 0.010 |
Why?
|
Concepts
(234)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(67)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_